Clinical trial · Observational
Value of Various Chemokines in the Detection and Follow up of RCC
NCT02022787CI-TRIAL-00017007unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study was designed as a pilot study to try and find a Chemokine that may be specific for renal cell carcinoma
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Clear Cell Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| patients with renal cell carcinoma | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Renal cell carcinoma
- description
- Patients with renal cell carcinoma scheduled for partial or radical nephrectomy
- interventionNames
- Other: patients with renal cell carcinoma
Primary outcomes (1)
- measure
- Measurement of the titers of chemokines before and after tumor resection
- timeFrame
- before nephrectomy (day of surgery)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: Patients with renal cell carcinoma of one or both kidneys scheduled for surgical resection \- Exclusion Criteria: Males with elevated PSA (prostatic specific antigen ) Any other untreated malignancy -
References
Publications (0)
Data not yet available
No reference posted for this study.